Purisal Nebuliser Solution

About Purisal 1.25 mg/3 ml Nebuliser Solution

Purisal 1.25 mg/3 ml Nebuliser Solution is made by Incepta Pharmaceuticals Ltd. It contains levosalbutamol, a short-acting beta-2 agonist used for bronchospasm in people with reversible obstructive airway disease.

There are 41 brands of Levosalbutamol listed in Bangladesh. 16 of them have a lower unit price than Purisal. The lowest listed price is Purilin 1 mg Tablet at ৳ 0.9 per unit.

What is Purisal 1.25 mg/3 ml Nebuliser Solution?

Purisal Nebuliser Solution is supplied by Incepta Pharmaceuticals Ltd. in a strength of 1.25 mg/3 ml, in 3 ml ampoules and a 10's pack. The active ingredient is levosalbutamol, the (R)-enantiomer of racemic salbutamol, a relatively selective beta-2 adrenergic receptor agonist. It works on beta-2 receptors in airway smooth muscle to help relax the muscle. It is a preservative-free, sterile, clear, colourless solution given by nebulisation. The doctor decides the dose and course for each person.

Uses of Purisal

Purisal Nebuliser Solution is used to treat or prevent bronchospasm in adults, adolescents and children who have reversible obstructive airway disease. It is a short-acting selective beta-2 adrenoceptor stimulant given by nebulisation. Whether it suits a particular person, and how it fits with other asthma or airway medicines, is for the doctor to decide.

How to use Purisal

Purisal Nebuliser Solution comes in unit-dose ampoules and is given by nebulisation; it needs no dilution before use. It must not be injected. The doctor decides the dose, how often it is given and how long the course lasts, including for children and for adults. Follow the instructions given by the doctor or pharmacist, and ask them if anything about using the nebuliser is unclear.

Side effects of Purisal

Beta-2 agonist therapy may cause potentially serious low potassium levels, and this can be worsened by low oxygen. Other side effects that may occur include palpitation, fine tremor of skeletal muscle (particularly the hand) and muscle cramps. In a few cases, nervousness, headache, dizziness, fatigue and sleeplessness have been reported. Tell the doctor or pharmacist if any of these occur or bother you.

Safety and precautions

Purisal Nebuliser Solution must not be injected. It should be used with caution in people with cardiovascular disorders, especially coronary insufficiency, hypertension and cardiac arrhythmias, and in people with convulsive disorders, hyperthyroidism or diabetes mellitus, or who are unusually responsive to sympathomimetic amines. There are no adequate and well-controlled studies in pregnant women, so it should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether levosalbutamol is excreted in human milk, so caution is needed in nursing women. Ask the doctor first if any of these apply.

Frequently asked questions

What is Purisal Nebuliser Solution used for and what kind of medicine is it?

It is used to treat or prevent bronchospasm in adults, adolescents and children with reversible obstructive airway disease. It is a short-acting selective beta-2 adrenoceptor stimulant, given by nebulisation. The doctor decides whether it is suitable for you.

Which medicines may interact with Purisal Nebuliser Solution?

Other short-acting sympathomimetic aerosol bronchodilators or epinephrine should be used with caution with it, and additional adrenergic drugs by any route should be used with caution to avoid harmful cardiovascular effects. Beta-blockers may block its effect and may cause severe bronchospasm in asthmatic patients. Tell the doctor or pharmacist about all medicines you use.

Who should avoid Purisal Nebuliser Solution or ask the doctor first?

Ask the doctor first if you have cardiovascular disorders such as coronary insufficiency, hypertension or cardiac arrhythmias, convulsive disorders, hyperthyroidism or diabetes mellitus, or if you are unusually responsive to sympathomimetic amines. It must not be injected. Ask the doctor if you are pregnant or breastfeeding.

What is the price of Purisal Nebuliser Solution?

The listed price is ৳ 20.00. Ask the pharmacist for the current price and availability.

Indications

Levosalbutamol Nebuliser Solution or Inhaler  is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children with reversible obstructive airway disease.

Pharmacology

Levosalbutamol Nebuliser Solution is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of Levosalbutamol, the (R)-enantiomer of the drug substance racemic salbutamol. Levosalbutamol Hydrochloride is a relatively selective β2 adrenergic receptor agonist.

Activation of β2 adrenergic receptors on airway smooth muscle leads to the activation of adenylcyclase and to an increase in the intracellular concentration of cyclic AMP. This increase in cAMP leads to the activation of protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular ionic calcium concentrations, resulting in relaxation. Levosalbutamol relaxes the smooth muscles of all airways, from the trachea to the terminal bronchioles. Levosalbutamol acts as a functional antagonist to relax the airway irrespective of the spasmogen involved, thus protecting against all bronchoconstrictor.

Dosage & Administration

Nebuliser Solution: This Nebuliser Solutions supplied in unit-dose ampoules and requires no dilution before administration by nebulization.
  • Children (6 months-11 years): The recommended dosage is 0.31 mg administered three times a day, by nebulization. Routine dosing should not exceed 0.63 mg three times a day. 
  • Adults and Adolescents above 12 years old: The recommended starting dosage is 0.63 mg administered three to four times a day, every 6 to 8 hours, by nebulization. 
  • Patients 12 years of age and older: With more severe asthma or patients who do not respond adequately: 0.63 mg of Levosalbutamol Nebuliser Solution may benefit from a dosage of 1.25 mg three times a day.
Inhaler: You should take your Levosalbutamol Inhaler as needed for an asthma attack at any time of day, with or without food, by taking 1-2 puffs up to 4 times daily and no more than 8 puffs in 24 hours. If you are using your Levosalbutamol Inhaler more than 3-4 times a week this may indicate that your asthma is not well controlled and you may need to review your medication. You can also use your Levosalbutamol Inhaler to prevent allergy or exercise induced asthma by taking 2 puffs 15 minutes before exercise or exposure to a known allergen.

Interaction

Other short-acting sympathomimetic aerosol bronchodilators or epinephrine should be used with caution with Levosalbutamol. If additional adrenergic drugs are to be administered by any route, they should be used with caution to avoid deleterious cardiovascular effects.

Beta-blockers: Beta-adrenergic receptor blocking agents not only block the pulmonary effect of beta-agonists such as Levosalbutamol Nebuliser Solution or Inhaler, but may also produce severe bronchospasm in asthmatic patients. However, under certain circumstances, e.g. prophylaxis after myocardial infarction, there may be no acceptable alternatives to the use of beta-adrenergic blocking agents in patients with asthma. In this setting, cardio selective beta-blockers could be considered with caution.

Diuretics: The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics can be acutely worsened by beta-agonists when the recommended dose of the beta-agonist is exceeded.

Digoxin: It is necessary to carefully evaluate the serum digoxin levels in patients who are currently receiving digoxin and Levosalbutamol Nebuliser Solution or Inhaler. 

Monoamine Oxidase Inhibitors or Tricyclic Antidepressants: Levosalbutamol Nebuliser Solution or Inhaler should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, or within 2 weeks of discontinuation of such agents.

Side Effects

Potentially serious hypokalaemia may result from beta 2 - agonist therapy. This effect may be potentiated by hypoxia. Other side effects such as palpitation, fine tremors of the skeletal muscle (particularly the hand) and muscle cramps may occur. In few cases nervousness, headache, dizziness, fatigue and sleeplessness have also been reported.

Pregnancy & Lactation

Pregnancy: There are no adequate and well-controlled studies of Levosalbutamol Nebuliser Solution in pregnant women. Levosalbutamol Solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Lactation: It is not known whether Levosalbutamol is excreted in human milk. Caution should be exercised when Levosalbutamol Nebuliser Solution is administered to a nursing woman.

Precautions & Warnings

Levosalbutamol Hydrochloride, like all sympathomimetic amines, should be used with caution in patients with cardiovascular disorders, especially coronary insufficiency, hypertension, and cardiac arrhythmias; in patients with convulsive disorders, hyperthyroidism, or diabetes mellitus; and in patients who are unusually responsive to sympathomimetic amines. Levosalbutamol Nebuliser Solution or Inhaler must not be injected.

Overdose Effects

The expected symptoms with over dosage are those of excessive beta-adrenergic receptor stimulation and/or occurrence or exaggeration of any of the symptoms listed under side effects. Treatment consists of discontinuation of Levosalbutamol Nebuliser Solution or Inhaler together with appropriate symptomatic therapy. The judicious use of a cardioselective beta-receptor blocker may be considered.

Storage Conditions

Store below 25°C. Protect from light. Do not refrigerate.

Alternative brands of Levosalbutamol

Other brands with the same generic name, cheapest first.

See all 41 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.